A Study of Lonitoclax (ZE50-0134) in Relapsed or Refractory B-cell Malignancies

Clinical trial NCT06708897 · RECRUITING

Trial details

NCT number: NCT06708897
Sponsor: Lomond Therapeutics Holdings, Inc.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

CLL / SLL CLL (Chronic Lymphocytic Leukemia)SLL (Small Lymphocytic Lymphoma)Marginal Zone Lymphoma(MZL)Lymphoplasmacytic Lymphoma/Waldenström Macroglobulinemia

Start date: 2025-04-08
Primary completion: 2028-01-01
Enrollment: 84

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.